Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Ltd. ( (AU:OSX) ) just unveiled an update.
Osteopore Ltd has disclosed that investor Sun Jingsi has become a substantial shareholder in the company, acquiring 50,000,000 fully paid ordinary shares. The stake represents 9.76% of Osteopore’s voting power, indicating a significant new position on the company’s share register.
According to the filing, Sun Jingsi acquired the shares for A$262,500, and holds them directly without associated entities. The move introduces a sizeable single shareholder, which may influence future governance dynamics and signals renewed investor interest in Osteopore’s equity.
The most recent analyst rating on (AU:OSX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Osteopore Ltd. stock, see the AU:OSX Stock Forecast page.
More about Osteopore Ltd.
Osteopore Ltd is a medical technology company focused on regenerative bone and tissue healing solutions. It develops and manufactures bioresorbable 3D-printed implants designed to support natural bone regeneration, targeting orthopedic, craniofacial, and related surgical markets in healthcare systems worldwide.
Average Trading Volume: 31,878,288
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.86M
See more insights into OSX stock on TipRanks’ Stock Analysis page.

